Revised National Institute For Health And Clinical Excellence Guidelines On The Treatment Of Age-Related Macular Degeneration
EDM number 1399 in 2007-08, proposed by Lee Scott on 23/04/2008.
Categorised under the topics of Health finance and Health services.
That this House welcomes the change in draft guidance from the National Institute for Health and Clinical Excellence (NICE) on the treatment of wet age-related macular degeneration through the prescription of Lucentis; notes with concern that its additional proposal to ration patients to 14 injections of Lucentis paid for by the NHS would deny further treatment to those unable to afford it privately; and calls on NICE to reconsider its recommendations on treatment using the drug Macugen.
This motion has been signed by a total of 35 MPs.
Download raw data as csv or xml.